News | Radiation Therapy | October 17, 2018

IBA Dosimetry Enters Interoperability Agreement With Varian for Dolphin Monitoring

After successful validation of Dolphin interoperability, online patient dose measurements during actual treatment delivery will enable verification of the correctness of each treatment fraction

IBA Dosimetry Enters Interoperability Agreement With Varian for Dolphin Monitoring

October 17, 2018 — IBA (Ion Beam Applications S.A.) announced it has entered into an agreement with Varian with the goal of validating the Dolphin transmission detector for online monitoring of patient treatment.

With the health, security and safety of patients in focus, modern radiation therapy has become highly specialized, which has led to different complex treatment techniques being developed and used daily in patient cancer therapy. This in turn requires new and comprehensive quality assurance (QA) solutions that address the growing number of possible sources and impact of dose deviations, in particular for high-dose cases.

For online patient plan monitoring, IBA Dosimetry is set to release the Dolphin online solution with its Compass 3D verification software, and has therefore entered into an interoperability agreement with Varian.

The Dolphin online functionality enables the measurement of each fraction dose and the verification of the actual radiation dose delivered to patients. The ability to measure treatment accuracy fraction by fraction will provide the confidence and safety needed to deliver the highest quality of care to the patient.

Dolphin includes the following five checks for verification of the complete treatment chain:

  • Real measurement of the plan delivery. In contrast to solutions that purely recalculate the patient plan via log files, the Dolphin advanced high-resolution ionization chamber detector array enables real measurements of each fraction dose and detection of errors in treatment delivery, such as beam line defects, multileaf collimator (MLC) deviations, dose rate changes, flatness/symmetry drifts, gantry positioning errors, etc.;
  • Verification of the real patient plan where no surrogate QA plan is required;
  • Secondary dose calculation with treatment planning system (TPS)-class algorithm. Secondary verification of the TPS dose calculation enables detection of errors in the TPS algorithm, TPS performance or in the TPS export;
  • Machine constancy checks with myQA. In addition, Dolphin’s detector array is optimized to find deviations and trends in linear accelerator (LINAC) constancy for profiles, output and wedge factors; and
  • Independent verification of the treatment planning system. The independent beam model of Dolphin’s verification software enables detection of errors in the TPS configuration and performance, its beam model, commissioning, or the LINAC calibration
     

Dolphin is currently in clinical use around the world for advanced measurement-based pre-treatment patient QA.

For more information: www.iba-dosimetry.com

Related Content

Final rule includes mandatory participation for nearly 1,000 practices and does not allow sufficient time for transition

Getty Images

News | Radiation Oncology | September 21, 2020
September 21, 2020 — In response to the September 18 ...
According to a new report published by P&S Intelligence, the global radiotherapy market is expected to expand from $7.2M in 2019 to $17M by 2030.

Image courtesy of Accuray

Feature | Radiation Therapy | September 21, 2020 | By Melinda Taschetta-Millane
According to a...
Breast cancer patients whose disease has spread to their brains fare better if their metastases are picked up before they begin to cause symptoms, according to a study presented at the 12th European Breast Cancer Conference.

Getty Images

News | Breast Imaging | September 21, 2020
September 21, 2020 — Breast cancer patients whose disease has spread to their brains fare better if their metastases
Data from latest research presented at the ESMO Virtual Congress 2020 suggests COVID-19 pandemic halts cancer care and damages oncologists' wellbeing

Getty Images

News | Coronavirus (COVID-19) | September 17, 2020
September 17, 2020 — Delays and cancellation of cancer treatments and other safety measures undertaken to minimize th
Varian Drives Next Evolution of Proton Treatment Planning with Eclipse v16.1
News | Treatment Planning | September 15, 2020
September 15, 2020 — Varian announced it has received FDA 510(k) clearance for its Eclipse v16.1 treatment planning s
the Contrast Media Injectors Market is estimated to be USD 1.3 billion in 2020 and  projected to reach $1.9B by 2025, at a CAGR of 7.4% between 2020 and 2025

Getty Images

News | Contrast Media Injectors | September 02, 2020
September 2, 2020 — According to the new market research report "...
Single-dose radiotherapy replaces need for extra hospital visits, with benefits for patient safety and well-being

Getty Images

News | Women's Health | August 20, 2020
August 20, 2020— For most women with early breast cancer
A special issue of the Journal of Medical Imaging and Radiation Sciences features stories about the interpersonal skills beyond the technical aspects to care for and guide patients through medical imaging and radiation therapy procedures

Image courtesy of Canon

News | Patient Engagement | August 11, 2020
August 11, 2020 — "I went into the MRI
Global radiotherapy market revenue is set to expand from $7,222.4 million in 2019 to $17,194.4 million by 2030, at an 8.4% CAGR between 2020 and 2030, the key factor driving the market growth is the increasing number of cancer cases, according to the report published by P&S Intelligence.

Image courtesy of Elekta

News | Radiation Therapy | August 06, 2020
August 6, 2020 — Global ...